ENDRA Life Sciences Inc. cotiza a 5.04 USD y tiene una capitalización bursátil de $8M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic wa…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-1.09 | $-2.23 | $-2.10 | $-1.71 |
| Estimado | $-1.23 | $-1.23 | $-1.95 | $-2.27 |
| Sorpresa | +11.4% | -81.3% | -7.7% | +24.7% |
| Métrica | NDRA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -310.9% | -40.4% | -270.5% |
| ROA | -182.3% | -32.0% | -150.3% |
| Current Ratio | 1.29 | 2.84 | -1.55 |
| Debt / Equity | — | 0.28 | — |